4881.T
FunPep Company Limited
グロース · 医薬品 · 医薬品 · JP
JPY 50.00
+0.00%Year over year
Reported trailing growth
- Revenue
- -100.0%
- EBITDA
- —
- EBIT
- -1.4%
- EPS
- +6.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- -11.5%
Three-year CAGR
- Revenue
- -100.0%
- EBITDA
- -86.1%
- EBIT
- -82.9%
- Net income
- —
- EPS
- -57.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026